WallStreetZenWallStreetZen

NASDAQ: BNGO
Bionano Genomics Inc Stock Forecast, Predictions & Price Target

Analyst price target for BNGO

Based on 2 analysts offering 12 month price targets for Bionano Genomics Inc.
Min Forecast
$2.00+201.2%
Avg Forecast
$4.00+502.41%
Max Forecast
$6.00+803.61%

Should I buy or sell BNGO stock?

Based on 2 analysts offering ratings for Bionano Genomics Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their BNGO stock forecasts and price targets.

BNGO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-16
lockedlocked$00.00+00.00%2024-03-07

1 of 1

Forecast return on equity

Is BNGO forecast to generate an efficient return?
Company
N/A
Industry
17.41%
Market
62.53%

Forecast return on assets

Is BNGO forecast to generate an efficient return on assets?
Company
N/A
Industry
11.84%

BNGO earnings per share forecast

What is BNGO's earnings per share in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$1.87
Avg 2 year Forecast
-$1.33

BNGO vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
BNGO$0.66$4.00+502.41%Strong Buy
POCI$6.00N/AN/A
RVP$1.16N/AN/A
FEMY$1.15$11.67+914.52%Strong Buy
EKSO$1.38$6.25+352.90%Strong Buy

Bionano Genomics Stock Forecast FAQ

Is Bionano Genomics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: BNGO) stock is to Strong Buy BNGO stock.

Out of 2 analysts, 1 (50%) are recommending BNGO as a Strong Buy, 1 (50%) are recommending BNGO as a Buy, 0 (0%) are recommending BNGO as a Hold, 0 (0%) are recommending BNGO as a Sell, and 0 (0%) are recommending BNGO as a Strong Sell.

If you're new to stock investing, here's how to buy Bionano Genomics stock.

What is BNGO's earnings growth forecast for 2024-2025?

(NASDAQ: BNGO) Bionano Genomics's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 26.17%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 20.42%.

Bionano Genomics's earnings in 2024 is -$226,791,000.On average, 1 Wall Street analyst forecast BNGO's earnings for 2024 to be -$125,022,223, with the lowest BNGO earnings forecast at -$125,022,223, and the highest BNGO earnings forecast at -$125,022,223.

In 2025, BNGO is forecast to generate -$88,919,549 in earnings, with the lowest earnings forecast at -$88,919,549 and the highest earnings forecast at -$88,919,549.

What is BNGO's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: BNGO) forecast ROE is N/A, which is considered weak.

What is BNGO's Price Target?

According to 2 Wall Street analysts that have issued a 1 year BNGO price target, the average BNGO price target is $4.00, with the highest BNGO stock price forecast at $6.00 and the lowest BNGO stock price forecast at $2.00.

On average, Wall Street analysts predict that Bionano Genomics's share price could reach $4.00 by May 16, 2025. The average Bionano Genomics stock price prediction forecasts a potential upside of 502.41% from the current BNGO share price of $0.66.

What is BNGO's Earnings Per Share (EPS) forecast for 2024-2025?

(NASDAQ: BNGO) Bionano Genomics's current Earnings Per Share (EPS) is -$6.02. On average, analysts forecast that BNGO's EPS will be -$1.87 for 2024, with the lowest EPS forecast at -$1.87, and the highest EPS forecast at -$1.87. In 2025, BNGO's EPS is forecast to hit -$1.33 (min: -$1.33, max: -$1.33).

What is BNGO's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: BNGO) forecast ROA is N/A, which is lower than the forecast US Medical Instruments & Supplies industry average of 11.84%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.